세계 절제 기기 시장 규모는 2024년 65억 달러에 달했습니다. IMARC Group은 2033년에는 155억 달러에 달하고, 2025-2033년 9.7%의 연평균 성장률(CAGR)을 보일 것으로 예측하고 있습니다. 생명을 위협하는 질병 증가, 비정상 조직을 제거하기 위한 전기생리학의 보급, 로봇 네비게이션 시스템을 탑재한 차세대 절제 기기의 개발은 시장을 주도하는 주요 요인 중 하나입니다.
절제 기기는 조직의 제거 또는 파괴를 목적으로 하는 다양한 의료 시술에 사용되는 의료기기 및 도구로, 일반적으로 특정 질환을 치료하거나 관리할 목적으로 사용됩니다. 이 기구들은 열, 저온, 고주파 등의 에너지를 표적 조직에 공급하여 제거하거나 변화를 일으키는 방식으로 작동합니다. 절제술은 일반적으로 통증이 적고, 회복 시간이 짧고, 합병증 위험이 낮아 기존 수술 방법보다 선호되는 경우가 많습니다.
이 시장은 암, 심방세동, 만성정맥부전(CVI)과 같은 생명을 위협하는 질환의 유병률 증가 등 몇 가지 중요한 요인에 의해 성장하고 있습니다. 이러한 질병 이환율 증가는 효과적인 절제술에 대한 수요를 강조하고 있습니다. 또한 저침습적 절제술이 가능하다는 인식이 일반인들 사이에서 확산되고 있는 것도 시장 확대에 힘을 보태고 있습니다. 이러한 시술은 통증 감소, 흉터 최소화, 불편감 감소, 환자의 회복 시간 단축 등 여러 가지 장점이 있습니다. 또한, 비정상적인 조직을 제거하여 부정맥이나 심근경색을 치료하는 전기생리학적 시술이 널리 채택되고 있는 것도 시장 성장에 크게 기여하고 있습니다. 또한, 각 제조업체들은 표재성 정맥류 역류를 효과적으로 치료하기 위해 비열성, 비점액성, 비경화성 정맥 내 절제 기기를 개발하여 진화하는 의료 수요에 부응하고 있습니다.
생명을 위협하는 질병 증가
암은 여전히 전 세계 주요 사망 원인 중 하나이며, 최근 들어 그 발병률이 증가하고 있습니다. 특히 종양학에서 절제술은 외과적 수술을 대체할 수 있는 최소침습적 수술로 각광받고 있습니다. 간, 신장, 폐 등 다양한 장기의 암 조직을 파괴하기 위해 채택되고 있습니다. 또한, CVI는 다리의 정맥이 혈액을 심장으로 충분히 돌려보내지 못해 통증, 부종, 피부 변화를 유발하는 질환입니다. 정맥 내 소작술은 기능부전에 빠진 정맥을 폐쇄하여 CVI를 치료하는 방법으로 현재 일반적으로 사용되고 있습니다. 생활습관 및 노화에 따른 CVI 증가로 정맥 치료용 절제 기기에 대한 수요가 증가하고 있습니다.
전기생리학의 보급
전기생리학은 심장의 전기적 활동을 다루는 순환기학의 한 분야입니다. 심방세동을 포함한 다양한 부정맥의 진단과 치료에 효과적이기 때문에 도입이 급증하고 있습니다. 전기생리학적 유도에 의한 절제 치료는 심장의 비정상적인 전기 신호의 발생원을 정확히 찾아내어 제거합니다. 이 접근법은 많은 심장 리듬 장애에 대한 표준 치료법이 되었으며, 환자들에게 증상 완화와 삶의 질을 향상시킬 수 있는 기회를 제공합니다. 또한, 전기생리학적 유도하 절제술의 유용성을 인식하는 의료진이 증가함에 따라 그 채택이 확산되고 있으며, 관련 절제 기기 및 장비에 대한 수요가 증가하고 있습니다.
차세대 절제 기기와 로봇 네비게이션 시스템의 융합
절제 기기 분야의 기술 발전은 큰 원동력이 되고 있습니다. 차세대 절제 기기에는 로봇 내비게이션 시스템이 내장되어 있어 정확도, 정밀도, 정확성, 치료 성적이 향상되었습니다. 로봇 보조 절제술은 보다 정밀한 표적 조직 절제술을 가능케 하여 합병증 위험을 줄이고 환자 예후를 개선합니다. 이 로봇 시스템은 치료 부위의 실시간 이미지와 매핑을 제공하여 의료진이 복잡한 해부학적 구조를 보다 안정적으로 탐색할 수 있도록 돕습니다. 그 결과, 특히 최첨단 치료 옵션을 제공하고자 하는 의료시설에서 이러한 첨단 절제 기기의 채택이 증가하고 있습니다. 환자의 안전과 시술 성공률의 향상을 기대할 수 있기 때문에 이러한 장비에 대한 수요는 더욱 증가하고 있습니다.
The global ablation devices market size reached USD 6.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
Radiofrequency devices represent the most used device technology
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Cancer treatment holds the largest market share
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Hospitals accounts for majority of market share
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: